http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201023896-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faad4d14d50ca111925381f14c69abdf
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
filingDate 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b358ab09aec8d14d21cb469ae9d4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afea7f6eb98c687bccdfe6d9bbc0f0b3
publicationDate 2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201023896-A
titleOfInvention Adjuvant and method of using the adjuvant to increase lymphocyte function associated antigen-1 of cell
abstract An adjuvant and a method of using the adjuvant to increase lymphocyte function associated antigen-1 of cell. The adjuvant is diallyl disulfide that can add with oil-soluble vaccine or any injection to strengthen the efficacy of vaccine or injection, and therefore could to strengthen the immune reaction cause by major antigen.
priorityDate 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16590

Total number of triples: 16.